Abstracts tagged "Adolescent patients"

Abstract Number: 296 • 2012 ACR/ARHP Annual Meeting
A Brazilian Multicenter Study of 71 Children and Adolescents with Takayasu’s Arteritis
Maria Teresa Terreri¹, Gleice Clemente², Clovis Silva³, Silvana Sacchetti⁴, Adriana M. Sallum⁵, Lucia M. A. Campos⁶, Maria Carolina Santos⁴, Flavio Sztajnbok⁷, Rozana Gasparello de Almeida⁸, Virginia P. Ferriani⁹, Blanca E. Bica¹⁰, Teresa Robazzi¹¹, Marcia Bandeira¹², Andre Cavalcanti¹³, Marise Lessa¹⁴, Sheila K. Feitosa de Oliveira¹⁵ and Maria Odete Hilario¹⁶, ¹Pediatrics, Universidade Federal de São Paulo / UNIFESP, Sao Paulo, Brazil, ²Pediatrics, Universidade Federal de São Paulo/UNIFESP, São Paulo, Brazil, ³Pediatric Rheumatology, MD; PhD, São Paulo-SP, Brazil, ⁴Pediatrics, Santa Casa de Misericórdia de São Paulo, São Paulo, Brazil, ⁵Pediatric Rheumatology Unit, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo-SP, Brazil, ⁶Pediatric Rheumatology, University of São Paulo Medical School, São Paulo, Brazil, ⁷PRINTO, Genoa, Italy, ⁸Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil, ⁹Pediatrics, FMUSP-Ribeirao Preto, Ribeirao Preto, Brazil, ¹⁰International Investigator Consortium for MAS Diagnostic Criteria, Rio de Janeiro, Brazil, ¹¹Pediatrics, Universidade Federal da Bahia, Salvador, Brazil, ¹²Pediatrics, Hospital Infantil Pequeno Príncipe, Curitiba, Brazil, ¹³Universidade Federal de Pernambuco, Recife, Brazil, ¹⁴Pediatrics, Instituto de Pediatria e Puericultura Martagão Gesteira (IPPMG) da Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil, ¹⁵Pediatric Rheumatology, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil, ¹⁶Pediatrics, Universidade Federal de Sao Paulo / UNIFESP, Sao Paulo, Brazil
Background/Purpose: Takayasu’s arteritis is a chronic granulomatous disease that affects the vascular wall of the large arteries and can result in end organ damage. It…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].